Clinical trials
Hypoglycemia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 7 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
| Recruiting | 4 |
| Unknown status | 4 |
| Withdrawn | 4 |
| Terminated | 4 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut de Recherches Cliniques de Montreal | 26 |
| Eli Lilly and Company | 5 |
| Xeris Pharmaceuticals | 4 |
| Jaeb Center for Health Research | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| University of Manitoba | 3 |
| Zealand Pharma | 3 |
| University of British Columbia | 2 |
| University of Calgary | 2 |
| York University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoglycemia | 69 |
| Diabetes Mellitus, Type 1 | 51 |
| Insulin Resistance | 19 |
| Diabetes Mellitus, Type 2 | 7 |
| Diabetes Mellitus | 5 |
| Hyperglycemia | 3 |
| Hyperinsulinism | 2 |
| Metabolic Diseases | 2 |
| Pregnancy in Diabetics | 2 |
| Autoimmune Diseases | 1 |
Trials
Showing 51 to 69 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.